Filing Details
- Accession Number:
- 0001127602-12-028726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-16 17:26:56
- Reporting Period:
- 2012-10-15
- Filing Date:
- 2012-10-16
- Accepted Time:
- 2012-10-16 17:26:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1073431 | Life Technologies Corp | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 330373077 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1124164 | J Arnold Levine | 5791 Van Allen Way Carlsbad CA 92008 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-10-15 | 6,958 | $23.00 | 8,039 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-10-15 | 6,958 | $48.52 | 1,081 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2012-10-15 | 6,958 | $0.00 | 6,958 | $23.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-11-21 | 2012-10-17 | No | 4 | M | Direct |
Footnotes
- Options exercised and sold from grant #00015172 pursuant to 10b5-1 Trading Plan.
- Sale of common stock from exercise of Grant #00015172 pursuant to 10b5-1 Trading Plan.
- Weighted average from 42 transactions with prices ranging from $48.25 to $48.81. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.